{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:30:56Z","timestamp":1772897456080,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017605","name":"Shaanxi University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.108936","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T14:52:37Z","timestamp":1756565557000},"page":"108936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of novel 1,2,4-triazole schiff bases hybridized with 1,4-naphthoquinones as potent STAT3 inhibitors"],"prefix":"10.1016","volume":"165","author":[{"given":"Kai","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujun","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingchen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanxin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fayi","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dezhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruyi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10258","key":"10.1016\/j.bioorg.2025.108936_bb0005","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"396","author":"T. V.","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2025.108936_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113362","article-title":"Discovery of N-substituted sulfamoylbenzamide derivatives as novel inhibitors of STAT3 signaling pathway based on Niclosamide","volume":"218","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108936_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cytogfr.2019.10.005","article-title":"Novel activators and small-molecule inhibitors of STAT3 in cancer","volume":"49","author":"Yang","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bioorg.2025.108936_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109135","article-title":"Targeting STAT3 inhibition to reverse cisplatin resistance","volume":"117","author":"Sun","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108936_bb0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejmech.2015.08.054","article-title":"Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitors","volume":"103","author":"Pallandre","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108936_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12964-020-0527-z","article-title":"Role of STAT3 signaling pathway in breast cancer","volume":"18","author":"Ma","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bioorg.2025.108936_bb0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pharmthera.2015.10.004","article-title":"Targeting transcription factor STAT3 for cancer prevention and therapy","volume":"162","author":"Chai","year":"2016","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108936_bb0040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/cr.2008.18","article-title":"STAT3 as a target for inducing apoptosis in solid and hematological tumors","volume":"18","author":"Al Zaid Siddiquee","year":"2008","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108936_bb0045","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/CAD.0000000000000605","article-title":"A novel small molecular STAT3 inhibitor, 5Br-6b, induces apoptosis and inhibits migration in colorectal cancer cells","volume":"29","author":"Liu","year":"2018","journal-title":"Anti-Cancer Drugs"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108936_bb0050","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.molonc.2015.02.012","article-title":"Hitting the right spot: mechanism of action of OPB-31121, a novel and potent inhibitor of the signal transducer and activator of transcription 3 (STAT3)","volume":"9","author":"Brambilla","year":"2015","journal-title":"Mol. Oncol."},{"issue":"14","key":"10.1016\/j.bioorg.2025.108936_bb0055","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1111\/febs.13285","article-title":"STAT3 the oncogene - still eluding therapy?","volume":"282","author":"Wake","year":"2015","journal-title":"FEBS J."},{"issue":"26","key":"10.1016\/j.bioorg.2025.108936_bb0060","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.2174\/092986711796957284","article-title":"Small molecule inhibitors of STAT3 for Cancer therapy","volume":"18","author":"Zhao","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2025.108936_bb0065","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1158\/1078-0432.CCR-12-0792","article-title":"Targeting Stat3 abrogates EGFR inhibitor resistance in cancer","volume":"18","author":"Sen","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.bioorg.2025.108936_bb0070","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1038\/sj.onc.1210031","article-title":"A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo","volume":"26","author":"Iwamaru","year":"2007","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108936_bb0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.cji.0000211327.76266.65","article-title":"Stat3 as a potential target for Cancer immunotherapy","volume":"30","author":"Kortylewski","year":"2007","journal-title":"J. Immunother."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108936_bb0080","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1158\/0008-5472.CAN-12-3175","article-title":"A novel inhibitor of STAT3 Homodimerization selectively suppresses STAT3 activity and malignant transformation","volume":"73","author":"Zhang","year":"2013","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108936_bb0085","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2011.10.011","article-title":"Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells","volume":"315","author":"Huang","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioorg.2025.108936_bb0090","first-page":"41","article-title":"STAT3: a target to enhance antitumor immune response","volume":"344","author":"Lee","year":"2011","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108936_bb0095","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/13543784.2016.1195807","article-title":"Novel STAT 3 inhibitors for treating gastric cancer","volume":"25","author":"Cafferkey","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bioorg.2025.108936_bb0100","doi-asserted-by":"crossref","unstructured":"Y. Liu, S. Liao, S. Bennett, et al, STAT3 and its targeting inhibitors in osteosarcoma, Cell Prolif. 54 (2) (2021) e12974, doi:10.1111\/cpr.12974.","DOI":"10.1111\/cpr.12974"},{"key":"10.1016\/j.bioorg.2025.108936_bb0105","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ejmech.2018.03.053","article-title":"Discovery of new benzensulfonamide derivatives as tripedal STAT3 inhibitors","volume":"151","author":"Guo","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108936_bb0110","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","article-title":"Stattic: a small-molecule inhibitor of STAT3 activation and dimerization","volume":"13","author":"Schust","year":"2006","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108936_bb0115","first-page":"61","article-title":"Inhibitory effect of cucurbitacin I on hepatocellular carcinoma cells and its relation with anti\u00b7apoptotic factors related to STAT3 signaling pathway","volume":"27","author":"Wang","year":"2018","journal-title":"Chinese J. General Surgery"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108936_bb0120","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/art.38305","article-title":"STA-21, a promising STAT-3 inhibitor that reciprocally regulates Th17 and Treg cells, inhibits osteoclastogenesis in mice and humans and alleviates autoimmune inflammation in an experimental model of rheumatoid arthritis","volume":"66","author":"Park","year":"2014","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108936_bb0125","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1021\/jm400080c","article-title":"Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design","volume":"56","author":"Yu","year":"2013","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108936_bb0130","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1073\/pnas.1424171112","article-title":"Suppression of cancer relapse and metastasis by inhibiting cancer stemness","volume":"112","author":"Li","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2025.108936_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104661","article-title":"LYW-6, a novel cryptotanshinone derived STAT3 targeting inhibitor, suppresses colorectal cancer growth and metastasis","volume":"153","author":"Wang","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108936_bb0140","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/bph.14863","article-title":"LL1, a novel and highly selective STAT3 inhibitor, displays anti- colorectal cancer activities in vitro and in vivo","volume":"177","author":"Liu","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108936_bb0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmech.2018.03.054","article-title":"Design, synthesis and activity of BBI608 derivatives targeting on stem cells","volume":"151","author":"Zhou","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108936_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107955","article-title":"Design, synthesis, and biological evaluation of novel (E)-2-cyano-3-(4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-yl) derivatives as potent STAT3-targeting anticolorectal cancer agents","volume":"153","author":"Jiang","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2025.108936_bb0155","doi-asserted-by":"crossref","first-page":"15291","DOI":"10.1021\/acs.jmedchem.4c00872","article-title":"Natural product-inspired discovery of naphthoquinone-Furo-Piperidine derivatives as novel STAT3 inhibitors for the treatment of triple-negative breast Cancer","volume":"67","author":"Fan","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108936_bb0160","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13046-018-0914-0","article-title":"Inhibition of STAT3 blocks protein synthesis and tumor metastasis in osteosarcoma cells","volume":"37","author":"Zuo","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108936_bb0165","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/cam4.675","article-title":"Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin","volume":"5","author":"Yiming","year":"2016","journal-title":"Cancer Med."},{"issue":"14","key":"10.1016\/j.bioorg.2025.108936_bb0170","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/cncr.32954","article-title":"Napabucasin (BBI 608), a potent chemoradiosensitizer in rectal cancer","volume":"126","author":"Nagaraju","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108936_bb0175","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13046-019-1289-6","article-title":"Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells","volume":"38","author":"Han","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108936_bb0180","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s13577-021-00582-4","article-title":"STAT3 inhibitor BBI608 enhances the antitumor effect of gefitinib on EGFR-mutated non-small cell lung cancer cells","volume":"34","author":"Wang","year":"2021","journal-title":"Hum. Cell"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108936_bb0185","first-page":"244","article-title":"Synthesis and biological activities of novel pyrimidinederivatives containing 1,2,4-triazole","volume":"62","author":"Luo","year":"2023","journal-title":"Agrochemicals"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108936_bb0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13065-022-00887-x","article-title":"Design, synthesis and evaluation of novel 1, 2, 4-triazole derivatives as promising anticancer agents","volume":"16","author":"Emami","year":"2022","journal-title":"BMC Chem"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108936_bb0195","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1080\/07391102.2023.2239909","article-title":"Development of novel 1, 2, 4-triazole containing compounds with anticancer and potent anti-CB1 activity","volume":"42","author":"Y\u0131ld\u0131r\u0131m","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108936_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300345","article-title":"Synthesis of 1, 2, 4-triazole and 1, 3, 4-oxadiazole derivatives as inhibitors for STAT3 enzymes of breast cancer","volume":"356","author":"Fawzy","year":"2023","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.108936_bb0205","first-page":"3749","article-title":"Therapeutic strategies for targeting the IL-6\/STAT3 cytokine signaling pathway in inflammatory bowel disease","volume":"27","author":"Mitsuyama","year":"2007","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bioorg.2025.108936_bb0210","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccr.2005.05.007","article-title":"Nuclear interaction of EGFR and STAT3 in the activation of the iNOS\/NO pathway","volume":"7","author":"Lo","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2025.108936_bb0215","doi-asserted-by":"crossref","unstructured":"H. Li, Y. Qian, X. Wang, et al., Targeted activation of Stat3 in combination with paclitaxel results in increased apoptosis in epithelial ovarian cancer cells and a reduced tumour burden, Cell Prolif. 53 (1) (2020) e12719, doi:10.1111\/cpr.12719.","DOI":"10.1111\/cpr.12719"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108936_bb0220","first-page":"97","article-title":"In vitro assessment of BBI608 in 2D and 3D culture models for drug repositioning in oral squamous cell carcinoma","volume":"54","author":"Park","year":"2025","journal-title":"Oncol. Rep.J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.108936_bb0225","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2018.04.008","article-title":"BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC","volume":"428","author":"MacDonagh","year":"2018","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108936_bb0235","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1208\/s12249-025-03185-6","article-title":"Solid lipid nanoparticles: An innovative drug delivery system for enhanced bioavailability and targeted therapy","volume":"26","author":"Aggarwal","year":"2025","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108936_bb0240","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.pharma.2024.06.003","article-title":"Nanosuspensions: enhancing drug bioavailability through nanonization","volume":"83","author":"Chavhan","year":"2025","journal-title":"Ann. Pharm. Fr."},{"issue":"18","key":"10.1016\/j.bioorg.2025.108936_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202300155","article-title":"Stimuli-responsive prodrug chemistries for Cancer therapy","volume":"24","author":"Bargakshatriya","year":"2023","journal-title":"Chembiochem"},{"key":"10.1016\/j.bioorg.2025.108936_bb0250","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejmech.2018.10.067","article-title":"A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3)","volume":"162","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108936_bb0255","doi-asserted-by":"crossref","first-page":"106541","DOI":"10.1016\/j.bioorg.2023.106541","article-title":"Design, synthesis, and biological evaluation of novel napabucasin-melatonin hybrids as potent STAT3 inhibitors","volume":"136","author":"Zhang","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108936_bb0230","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11060-011-0564-y","article-title":"Tissue concentration of systemically administered antineoplastic agents in human brain tumors","volume":"104","author":"Pitz","year":"2011","journal-title":"J. Neurooncol."}],"updated-by":[{"DOI":"10.1016\/j.bioorg.2025.108984","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:03:36Z","timestamp":1772827416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825008168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":51,"alternative-id":["S0045206825008168"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108936","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel 1,2,4-triazole schiff bases hybridized with 1,4-naphthoquinones as potent STAT3 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108936"}}